Ward JF, Moul JW: Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing bio- chemical recurrence of prostate cancer. Curr Opin Urol, 15: 181-186, 2005.Ward JF, Moul JW (2005) Biochemical recurrence after definitive prostate cancer therapy. Part I: ...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here, we demonstrate in a murine prostate cancer model, t...
W. Prostate specific antigen recurrence after definitive therapy. J. Urol. 177, 1985–1991 (2007). Article PubMed Google Scholar Locker, G. Y. et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24, 5313–5327 (2006). ...
With respect to assessment of local recurrence, we found in a retrospective analysis of 80 PC-patients that early dynamic imaging starting immediately after injection of68Ga- PSMA-11 PET/CT allows the discrimination of urinary bladder activity from PC lesions [88]. A total of 55 lesions consiste...
(2007) DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients-Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and ...
These findings were consistent with specific areas including risk stratification (12% vs 75%), imaging and staging (11% vs 80%), treatment (16% vs 81%), recurrence (15% vs 73%), castration-sensitive prostate cancer (9% vs 84%), castration-resistant prostate cancer (8% vs 73%), and...
CHICAGO—Treatment with 200 µmol per day of sulforaphane for 20 weeks was “feasible, safe,” and inhibited histone deacetylase (HDAC) function in a single-arm study of 20 patients who had non-castrate biochemical (PSA)-recurrence of prostate cancer despite surgery or radiation (Abstract 5017...
(6.0-62.1)ng/mL.The mean chemical recurrence rates of group A 34.6%(9/28),group B 58.3%(5/8).The mean chemical recurrence time of group A 22(6-65) month,group B 10(6-56) month.The mortality rates of group A 25%(7/28),group B 75%(6/8).85.5%(22/28) of group A were ...
J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer. 15, 409–425 (2015). CAS PubMed PubMed Central Google Scholar Zaorsky, N. G. et al. The evolution of brachytherapy for prostate cancer. Nat. Rev. Urol. 14, 415–439 (2017)....
W. et al. Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer. Oncol. Rep. 20, 1403–1408 (2008). PubMed Google Scholar Langbein, S. et al. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and ...